Seeking men and women with with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia for a study of an investigational drug to reduce spleen volume.
Participants in this study will be randomly selected to receive either the investigational drug or the usual best available treatment. Participation will occur in multiple 28-day cycles of treatment.
What we're hoping for
We are studying whether an investigational drug is safe and effective compared to the best usual treatment in reducing spleen volume for people with Myelofibrosis
ClinicalTrials.gov Identifier: NCT04854096